Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq
March 3 (Reuters) - Metacrine Inc MTCR.PK :
* METACRINE INC - ON FEB 27, 2023, WAS NOTIFIED THAT NASDAQ
WILL
DELIST CO'S COMMON STOCK
* METACRINE INC - ON MARCH 3, 2023, NASDAQ FILED FORM 25
WITH THE
SEC
* METACRINE INC - DELISTING WILL BECOME EFFECTIVE ON MARCH
13,
2023, TEN DAYS AFTER FILING OF FORM 25
Source: (shorturl.at/yCKOT)
Further company coverage: MTCR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metacrine
See all newsMetacrine Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Brief: Metacrine Inc- On Jan 31, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Metacrine CEO Preston Klassen Was Terminated From All Positions